Formosa Pharmaceuticals, Inc.
6838.TWO
Price:
$28.05
Market Cap:
$4.23B
Formosa Pharmaceuticals, Inc., a late-preclinical and early clinical stage biopharmaceutical company, engages in developing drug candidates for ophthalmology, oncology, and anti-infectives in Taiwan. It is involved in developing APP13007, an aqueous-based ophthalmic nanosuspension that is in Phase III clinical trial for the treatment of post-operative pain and inflammatory eye conditions; TSY-0110, an antibody-drug conjugate; and TSY-0210, an antibiotic for drug resistant infections. The company also develops APP13002, a topical antibiotic for infectious eye diseases, such as blepharitis; and MPT0E028, a novel pan- histone deacetylase inhibitor for solid tumors, such as hepatomas and colorec...[Read more]
Industry
Biotechnology
IPO Date
2021-10-07
Stock Exchange
TWO
Ticker
6838.TWO
PE Ratio
[-14.02]
ROE
[-3.92%]
Current Ratio
[9.85]
Dividend Yield
[0%]
Enterprise Value
[4.03B]
Dividend History
The ROE as of December 2025 (TTM) for Formosa Pharmaceuticals, Inc. (6838.TWO) is -3.92%
According to Formosa Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -3.92%. This represents a change of 295.80% compared to the average of -0.99% of the last 4 quarters.
Formosa Pharmaceuticals, Inc. (6838.TWO) Historical ROE (quarterly & annually)
How has 6838.TWO ROE performed in the past?
The mean historical ROE of Formosa Pharmaceuticals, Inc. over the last ten years is -56.75%. The current -3.92% ROE has changed -93.09% with respect to the historical average. Over the past ten years (40 quarters), 6838.TWO's ROE was at its highest in in the June 2025 quarter at 4.10%. The ROE was at its lowest in in the September 2023 quarter at -12.24%.
Average
-56.75%
Median
-57.63%
Minimum
-110.17%
Maximum
0%
Formosa Pharmaceuticals, Inc. (6838.TWO) ROE by Quarter and Year
Discovering the peaks and valleys of Formosa Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 0%
Minimum Annual Increase = -Infinity%
Minimum Annual ROE = -110.17%
| Year | ROE | Change |
|---|---|---|
| 2024 | -12.99% | -54.02% |
| 2023 | -28.24% | -67.55% |
| 2022 | -87.03% | -14.74% |
| 2021 | -102.07% | -7.35% |
| 2020 | -110.17% | -Infinity% |
Formosa Pharmaceuticals, Inc. (6838.TWO) Average ROE
How has 6838.TWO ROE performed in the past?
The current ROE of Formosa Pharmaceuticals, Inc. (6838.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-42.75%
5-year avg
-68.10%
10-year avg
-56.75%
Formosa Pharmaceuticals, Inc. (6838.TWO) ROE vs. Peers
How is 6838.TWO’s ROE compared to its peers?
Formosa Pharmaceuticals, Inc.’s ROE is greater than AnnJi (-54.10%), greater than Senhwa Biosciences, Inc. (-27.83%), greater than Energenesis Biomedical CO.,LTD. (-32.50%), greater than BRIM Biotechnology, Inc. (-11.90%), greater than UnicoCell Biomed Co., Ltd. (-12.58%), greater than TWi Biotechnology, Inc. (-69.83%), greater than Medigen Biotechnology Corp. (-3.79%), greater than Orient EuroPharma Co., Ltd. (-5.85%), less than Synbio Tech Inc. (16.47%), greater than Shine-On BioMedical Co.,Ltd. (-11.76%),
| Company | ROE | Market cap |
|---|---|---|
| -54.10% | $4.33B | |
| -27.83% | $3.60B | |
| -32.50% | $3.82B | |
| -11.90% | $3.69B | |
| -12.58% | $4.81B | |
| -69.83% | $2.04B | |
| -3.79% | $4.26B | |
| -5.85% | $3.89B | |
| 16.47% | $3.25B | |
| -11.76% | $3.54B |
Build a custom stock screener for Formosa Pharmaceuticals, Inc. (6838.TWO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Formosa Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Formosa Pharmaceuticals, Inc. (6838.TWO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Formosa Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Formosa Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for Formosa Pharmaceuticals, Inc. (6838.TWO)?
What is the highest ROE for Formosa Pharmaceuticals, Inc. (6838.TWO)?
What is the 3-year average ROE for Formosa Pharmaceuticals, Inc. (6838.TWO)?
What is the 5-year average ROE for Formosa Pharmaceuticals, Inc. (6838.TWO)?
How does the current ROE for Formosa Pharmaceuticals, Inc. (6838.TWO) compare to its historical average?